Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography
- PMID: 23969786
- DOI: 10.1097/AOG.0b013e318298def5
Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography
Abstract
Objective: To examine the prevalence, incidence, persistence, and resolution of ovarian abnormalities using serial transvaginal ultrasonography.
Methods: A group of 39,337 women in the University of Kentucky Ovarian Cancer Screening Program were monitored with 221,576 baseline and interval transvaginal ultrasonography.
Results: The transvaginal ultrasonogram was normal for first and all subsequent visits for 31,834 participants (80.9%), whereas 6,807 women (17.3%) had transvaginal ultrasonograms interpreted as abnormal and were monitored over 21,588 ultrasonograms. Ovarian cysts were more common in premenopausal (prevalence 34.9%, incidence 15.3%) than in postmenopausal women (prevalence 17.0%, incidence 8.2%). For the group with abnormalities, the initial transvaginal ultrasonogram was abnormal in 46.7% of the cases, of which 63.2% resolved to normal on subsequent ultrasonograms. Of 35,314 cases classified as normal on the first examination, 9.9% were abnormal on subsequent annual examinations. The abnormal findings were classified as follows: unilocular cysts (11.5%), cysts with septations (9.8%), cysts with solid areas (7.1%), and solid masses (1.8%). Many transvaginal ultrasonographic abnormalities were followed to resolution. Surgery was performed on 557 participants for 85 ovarian malignancies and 472 nonmalignancies. Over the duration of the study, the positive predictive value (PPV) increased from 8.1% to 24.7%.
Conclusion: Serial ultrasonography has shown that many ovarian abnormalities resolve, even if the initial appearance is complex, solid, or bilateral. Thus, it is advantageous to avoid a single transvaginal ultrasonographic abnormality as the sole trigger for surgery and to take a measured serial approach to reduce false-positive results and increase the PPV.
Level of evidence: II.
Comment in
-
Enhancing the needle count in the haystack: serial ultrasonography for low-to-moderate risk adnexal masses.Obstet Gynecol. 2013 Aug;122(2 Pt 1):198-200. doi: 10.1097/AOG.0b013e31829eaf56. Obstet Gynecol. 2013. PMID: 23969785 No abstract available.
Similar articles
-
Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter.Obstet Gynecol. 2003 Sep;102(3):594-9. doi: 10.1016/s0029-7844(03)00670-7. Obstet Gynecol. 2003. PMID: 12962948
-
Preoperative assessment of unilocular adnexal cysts by transvaginal ultrasonography: a comparison between ultrasonographic morphologic imaging and histopathologic diagnosis.Am J Obstet Gynecol. 2001 Jan;184(2):48-54. doi: 10.1067/mob.2001.108330. Am J Obstet Gynecol. 2001. PMID: 11174478
-
Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.Croat Med J. 2005 Oct;46(5):757-64. Croat Med J. 2005. PMID: 16158468
-
Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy.Obstet Gynecol. 1991 Jul;78(1):70-6. Obstet Gynecol. 1991. PMID: 2047071 Review.
-
Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature.Ultrasound Obstet Gynecol. 2013 Jan;41(1):80-9. doi: 10.1002/uog.12308. Epub 2012 Dec 17. Ultrasound Obstet Gynecol. 2013. PMID: 23001924 Review.
Cited by
-
Clinical value of ACR O-RADS combined with CA125 in the risk stratification of adnexal masses.Front Oncol. 2024 Aug 30;14:1369900. doi: 10.3389/fonc.2024.1369900. eCollection 2024. Front Oncol. 2024. PMID: 39281376 Free PMC article.
-
Enigma of Ovarian Cancer - Early detection Challenges and Solutions!J Midlife Health. 2024 Jan-Mar;15(1):3-4. doi: 10.4103/jmh.jmh_52_24. Epub 2024 Apr 4. J Midlife Health. 2024. PMID: 38764930 Free PMC article. No abstract available.
-
Ovarian Cancer surgical consideration is markedly improved by the neural network powered-MIA3G multivariate index assay.Front Med (Lausanne). 2024 May 2;11:1374836. doi: 10.3389/fmed.2024.1374836. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38756943 Free PMC article.
-
Xanthogranulomatous oophoritis mimicking a dermoid cyst with ovarian torsion: A case report and review of the literature.Case Rep Womens Health. 2024 Apr 4;42:e00603. doi: 10.1016/j.crwh.2024.e00603. eCollection 2024 Jun. Case Rep Womens Health. 2024. PMID: 38600914 Free PMC article.
-
Descriptive study of the real-world, long-term cost estimates and duration of use for hormonal and nonhormonal intrauterine devices using US commercial insurance claims.J Manag Care Spec Pharm. 2023 Dec;29(12):1303-1311. doi: 10.18553/jmcp.2023.29.12.1303. J Manag Care Spec Pharm. 2023. PMID: 38058139 Free PMC article.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11–30.
-
- Padilla LA, Radosevich DM, Milad MP. Accuracy of the pelvic examination in detecting adnexal masses. Obstet Gynecol 2000;96:593–8.
-
- Ueland FR, DePriest P, DeSimone C, Pavlik EJ, Lele SM, Kryscio RJ, et al.. The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size. Gynecol Oncol 2005;99:400–3.
-
- Management of adnexal masses. ACOG Practice Bulletin No. 83. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;110:201–14.
-
- Graham L. ACOG releases guidelines on management of adnexal masses. Am Fam Physician 2008;77:1320–3.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
